CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,823 JPY | +0.52% |
|
-2.09% | -9.72% |
| 05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| 05-01 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1,091B 6.98B 9.52B | Sales 2025 * | 1,134B 7.25B 9.89B | Capitalization | 7,894B 50.49B 68.84B |
|---|---|---|---|---|---|
| Net income 2024 * | 346B 2.21B 3.02B | Net income 2025 * | 368B 2.36B 3.21B | EV / Sales 2024 * | 6.47 x |
| Net cash position 2024 * | 838B 5.36B 7.31B | Net cash position 2025 * | 1,004B 6.42B 8.75B | EV / Sales 2025 * | 6.08 x |
| P/E ratio 2024 * |
22.9
x | P/E ratio 2025 * |
21.5
x | Employees | 7,604 |
| Yield 2024 * |
1.76% | Yield 2025 * |
1.86% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | +0.52% | ||
| 1 week | -2.09% | ||
| Current month | -4.50% | ||
| 1 month | -5.52% | ||
| 3 months | -15.46% | ||
| 6 months | +1.69% | ||
| Current year | -9.72% |
1 week
4 687.00
5 028.00
1 month
4 687.005 376.00
Current year
4 687.006 697.00
1 year
3 581.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
867.676 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 19 M€ | +11.51% | ||
| 1.87% | 57 M€ | +16.93% | ||
| 1.59% | 4 M€ | +17.11% | ||
| 1.53% | 64,792 M€ | +15.61% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 4,823 | +0.52% | 2 316 200 |
| 24-05-14 | 4,798 | -3.38% | 5,633,700 |
| 24-05-13 | 4,966 | +0.40% | 1,363,100 |
| 24-05-10 | 4,946 | +0.45% | 1,646,500 |
| 24-05-09 | 4,924 | -0.04% | 1,118,700 |
Delayed Quote Japan Exchange, May 15, 2024 at 02:00 am
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,798
JPY
Average target price
6,021
JPY
Spread / Average Target
+25.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.72% | 50.47B | |
| +31.06% | 688B | |
| +30.35% | 588B | |
| -3.42% | 364B | |
| +18.02% | 326B | |
| +4.27% | 285B | |
| +15.53% | 239B | |
| +10.16% | 210B | |
| -8.14% | 200B | |
| +8.12% | 167B |
- Stock Market
- Equities
- 4519 Stock